Onxeo to attend upcoming investor events — Onxeo deltager i kommende investormøder

Paris (France), Copenhagen (Denmark) Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces its participation to financial conferences in the coming months.

During these conferences, Onxeo’s management will present the recent achievements and the growth strategy of the Company to institutional and individual investors.

Meetings with institutional investors:

  • Société Générale – Biotech & Medtech CEO conference: Paris, November 5, 2015
  • Natixis Small and Midcap Conference: Paris, November 24, 2015
  • ODDO Forum: Lyon, January 7-8, 2016
  • JP Morgan Healthcare Conference: San Francisco, January 11-15, 2016

Meeting with individual investors:

  • Actionaria: Paris, November 20-21, 2015

151028EN Upcoming Investor Events

Paris (Frankrig), København (Danmark) Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), et innovativt selskab med speciale i udvikling af lægemidler til behandling af sjældne kræftsygdomme, har i dag offentliggjort, at selskabet deltager i finansielle konferencer i de kommende måneder.

På disse konferencer vil Onxeos ledelse præsentere selskabets seneste resultater og udviklingsstrategi over for institutionelle og private investorer.

Møder med institutionelle investorer

  • Société Générale – Biotech & Medtech CEO conference: Paris, 5. november 2015
  • Natixis Small and Midcap Conference: Paris, 24. november 2015
  • ODDO Forum: Lyon, 7.-8. januar 2016
  • JP Morgan Healthcare Conference: San Francisco, 11.-15. januar 2016

Møde med private investorer

  • Actionaria: Paris, 20.-21. november 2015

151028DK Upcoming Investor Events